CSI Market
Sign In | Register

Keros Therapeutics Inc (KROS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KROS Annual Balance Sheets →
Tracking balance sheet results across Keros Therapeutics Inc to Mar 31 2025 helps illustrate how Mar 31 2026's financial position has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent281.50
Cash & Short-term Investments281.00
Accounts receivable0.40
Income Taxes Receivable, Current NO2.25
Prepaid Expense And Other Assets Current6.53
Total Current Assets290.68
Equipment/Property/Plant Net3.96
Other Assets, Noncurrent17.65
Operating Lease Right Of Use Asset16.21
Restricted Cash Noncurrent1.45
Total Assets312.29
Liabilities
Accounts Payable, Current AC1.49
Accrued Liabilities, Current AC8.86
Other Liabilities, Current2.50
Accrued Income Taxes, Current TA0.00
Total Current Liabilities12.85
Total Long-term Debt0.00
Other liabilities, Noncurrent13.81
Operating Lease Liability Current2.50
Operating Lease Liability Noncurrent13.81
Total Liabilities26.66
Stockholders' Equity
Treasury Stock Common Value-384.56
Common Stock Value0.00
Additional Paid In Capital Common Stock1,175.66
Retained Earnings / Accumulated Deficit-505.47
Other Equity0.00
Common Stockholder's Equity285.63
Total Stockholder's Equity285.63
Liabilities & Stockholder's Equity312.29
4 historic quarters locked

Sign in to unlock the full Keros Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Keros Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001664710-26-000049

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.